Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MD
Strong BuyFull HouseAPPROVEPediatrix Medical Group, Inc. · Healthcare · United States · $2.2B · Avg Vol: $20M/d
Eligibility met via stable composite scores; active management buybacks combined with upward EPS revisions provide strong conviction of underlying value.
COMPANY DESCRIPTION
Pediatrix Medical Group, Inc. is a leading provider of physician services specializing in neonatology, anesthesiology, and maternal-fetal medicine to hospitals and patients throughout the United States. The company's strength lies in its extensive network of highly specialized clinicians and deep clinical expertise in critical care for women and children. This focused service offering and integrated practice management capabilities establish it as a key partner in healthcare delivery.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0B | 2.0B | 2.0B | 1.9B | -1.0% | 2.0B | 2.0B | 2.0B | 2.5% |
| EPS | 0.80 | -0.72 | -1.15 | 1.99 | 35.6% | 2.09 | 2.29 | 2.38 | 9.4% |
| Shares | 82.9M | 84.0M | 85.9M | 83.0M | +0.0% | 81.3M | — | — | — |
| Debt | 717.1M | 701.6M | 662.3M | 634.6M | -4.0% | 620.0M | — | — | — |
| Equity | 891.6M | 849.1M | 764.9M | 865.9M | -1.0% | — | — | — | — |
| Op CF | 166.9M | 137.3M | 206.6M | 271.1M | 17.5% | 246.9M | — | — | — |
| Inv CF | -57.0M | -48.2M | -35.4M | -18.3M | — | — | — | — | — |
| Fin CF | -487.6M | -25.7M | -14.5M | -107.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MD | Pediatrix Medical Group, Inc.(you) | $2.2B | 97 | Strong Buy |
| ADUS | Addus HomeCare Corporation | $2.2B | 93 | Strong Buy |
| GRDN | Guardian Pharmacy Services, Inc. | $2.3B | 93 | Strong Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.9B | 96 | Strong Buy |
| HCSG | Healthcare Services Group, Inc. | $1.5B | 94 | Strong Buy |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
| NUTX | Nutex Health Inc. | $1.3B | 100 | Strong Buy |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
| ARDT | Ardent Health, Inc. | $1.5B | 88 | Strong Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
Peer medians: ROE -30.2% · P/E 27.1x · Gross margin 58.3%